Miro3D for Wounds

This trial examines wound healing with standard treatments alone versus standard treatments plus Miro3D, a special 3D framework that supports and protects the wound. The goal is to determine if Miro3D can improve healing for two types of wounds: complex soft tissue wounds, such as those requiring surgery for serious infections, and chronic pressure ulcers that have not healed well with regular care. Individuals with wounds in these categories, including those with serious foot infections or pressure ulcers that have not improved after four weeks of typical treatment, might be suitable candidates for the trial. As an unphased trial, this study provides patients the opportunity to explore innovative treatment options that could enhance healing outcomes.

The trial information does not specify if you need to stop taking your current medications. However, if you are using investigational drugs or therapies, you must stop them at least 30 days before joining the trial.

Research has shown that the Miro3D Wound Matrix is safe for humans. The FDA has approved it for treating severe skin injuries, confirming it meets safety standards for these conditions. The Miro3D is a special wound dressing made from pig liver tissue, designed to help heal deep and difficult wounds.

Studies have found that patients tolerate the Miro3D Wound Matrix well, with no major safety concerns reported. This suggests it is unlikely to cause harmful side effects when used correctly.

The Miro3D Wound Matrix is unique because it offers a new approach to healing complex soft tissue wounds and chronic pressure ulcerations. Unlike standard care options that primarily focus on dressing and maintaining a clean environment, Miro3D uses a three-dimensional scaffold that provides structural support to the wound, promoting tissue regeneration. Researchers are excited about this treatment as it might accelerate healing by offering a more conducive environment for cell growth, potentially reducing recovery time compared to traditional methods.

Research has shown that the Miro3D Wound Matrix may aid in healing difficult soft tissue wounds and long-lasting pressure sores. In this trial, participants with complex soft tissue wounds will be randomized to receive either standard of care (SOC) alone or SOC plus Miro3D. Similarly, participants with chronic pressure ulceration will be randomized to SOC plus Miro3D or SOC alone. Studies with diabetic foot ulcers found that patients using Miro3D alongside standard care experienced no harmful effects, indicating its safety. For long-lasting pressure sores, data shows that Miro3D can significantly reduce these wounds, with some studies noting a reduction of 50% or more after four weeks. Miro3D provides a 3D structure that supports collagen, helping wounds heal by giving them shape and protection. Overall, early findings suggest that Miro3D could be a valuable addition to standard wound care treatments.¹³⁶⁷⁸